Omkar Speciality Chemicals Ltd: Intrinsic Value & Share Price Analysis

Fair Value

₹9.45Undervalued by 177.13%vs CMP ₹3.41

P/E (15.0) × ROE (8.5%) × BV (₹9.09) × DY (2.00%)

Defaults: P/E=15

₹12.64Undervalued by 270.67%vs CMP ₹3.41
MoS: +73% (Strong)Confidence: 59/100 (Moderate)Models: All 4: Undervalued
ModelCategoryValueWeightSignal
PE-ROEEarnings₹11.5839%Under (+239.6%)
Net Asset ValueAssets₹9.1024%Under (+166.9%)
ROCE CapitalReturns₹20.3320%Under (+496.2%)
Revenue MultipleRevenue₹11.1718%Under (+227.6%)
Consensus (4 models)₹12.64100%Undervalued

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: 22.6% · Defaults: P/E=15

*Investments are subject to market risks

Analysis summary

Data coverage: Price-data record updated 24 September 2026, 3:09 am +05:30. Annual results through Mar 2022; quarterly results through Jun 2022; cash flow through Mar 2026. Each section can have a different reporting period. The share price is not live.

Valuation in context

Omkar Speciality Chemicals Ltd: the stored intrinsic value estimate is ₹12.64, compared with a stored share price of ₹3.41. The model value is 270.7% above that quote. The model classifies this as undervalued; it is an estimate dependent on the inputs and assumptions, not a price target or a buy/sell recommendation.

Operating performance

Revenue for Mar 2022 was ₹23.00 Cr, versus ₹45.00 Cr in Mar 2021 (-48.9% year on year). Net profit for Mar 2022 was ₹-13.00 Cr, versus ₹2.00 Cr in Mar 2021. These are the latest annual periods stored on this page; check the quarterly table separately for more recent developments.

Cash generation

For the same Mar 2022 period, operating cash flow was ₹0.89 Cr against net profit of ₹-13.00 Cr.A cash-to-profit ratio is not meaningful with zero or negative profit.

Balance-sheet check

Reported borrowings were ₹3.11 Cr in Mar 2026. Read this alongside cash, interest costs and repayment obligations; reserves are an accounting balance and are not the same as available cash.

How to use the valuation and peer comparisons

The Intrinsic Value panel combines the available model estimates using the displayed weights. Earnings, cash-flow, dividend and asset-based methods can give very different answers. The displayed 12% cost of equity and 4% terminal growth assumptions apply where relevant; historical EPS growth is not a promise of future growth. Use the individual values and their spread to judge sensitivity.

The peer group follows the stored industry classification and may include different business models. Compare reporting periods, leverage and recurring earnings before interpreting a valuation gap. For banks and other financial businesses, capital adequacy and asset quality can be more informative than industrial-company cash-flow ratios.

Sources: Company data source. Check the company filings linked by the source for the reporting basis and exceptional items.

Automatically generated interpretation of the stored financial data, not a separately researched analyst opinion. Missing data is not evidence of poor performance. New filings become available here after the existing data refresh process captures them.

Investment Snapshot

38
Omkar Speciality Chemicals Ltd scores 38/100 (Weak)
Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison
Stock Health28/100 · Weak
ROE 8.5% AverageD/E 1.06 High debtInterest Coverage 4.0x AdequateProfitable 1/5 available years Reported history
Smart Money60/100 · Moderate
FII holding stable No changePromoter increased by 80.29% PositiveShareholders down 100% Consolidation
Earnings Quality60/100 · Moderate
OPM stable around -5% SteadyWorking capital: -3,296 days (improving) Efficient
Quarterly Momentum15/100 · Weak
Revenue (4Q): -59% YoY DecliningProfit (4Q): -1,336% YoY DecliningOPM: -25.4% (down 20.0% YoY) Margin pressure
Industry Rank40/100 · Moderate
3Y sales CAGR: -19% Shrinking

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores use stored reporting periods and are screening indicators, not investment recommendations. Missing health ratios are excluded. Broad industry groups and financial-sector accounting can limit comparability.

Advertisements

Share Price and Basic Stock Data

Last Updated: September 24, 2026, 3:09 am

Market Cap 7.02 Cr.
Current Price 3.41
Intrinsic Value₹12.64
High / Low 6.40/3.35
Stock P/E
Book Value 9.09
Dividend Yield0.00 %
ROCE%
ROE8.49 %
Face Value 10.0
PEG Ratio0.00

Understand these figures: how to read the P/E ratio, ROE versus earnings per share, and calculate intrinsic value.

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Omkar Speciality Chemicals Ltd

Competitors

Stock Name Market Cap Current Price High / Low Stock P/E Book Value Dividend Yield ROCE ROE Face Value
HP Adhesives Ltd 328 Cr. 35.6 53.0/26.3140 20.41.12 %5.61 %4.03 % 2.00
Haryana Leather Chemicals Ltd 28.0 Cr. 57.0 84.7/50.221.0 91.31.75 %8.13 %5.36 % 10.0
Hardcastle & Waud Mfg Co Ltd 55.8 Cr. 820 1,048/60210.7 7460.00 %11.3 %10.2 % 10.0
Grauer & Weil (India) Ltd 3,908 Cr. 86.2 92.0/49.724.4 23.90.58 %20.6 %15.2 % 1.00
DMCC Speciality Chemicals Ltd 739 Cr. 296 333/19118.5 99.30.84 %14.8 %11.5 % 10.0
Industry Average16,509.72 Cr1,111.4747.07191.320.53%12.24%9.75%6.41

All Competitor Stocks of Omkar Speciality Chemicals Ltd

Quarterly Result

MetricJun 2019Sep 2019Dec 2019Mar 2020Jun 2020Sep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022
Sales 10.7018.9714.4312.795.1416.8612.1610.977.364.236.345.053.74
Expenses 10.3117.8814.1014.834.8613.809.2010.787.766.556.218.164.69
Operating Profit 0.391.090.33-2.040.283.062.960.19-0.40-2.320.13-3.11-0.95
OPM % 3.64%5.75%2.29%-15.95%5.45%18.15%24.34%1.73%-5.43%-54.85%2.05%-61.58%-25.40%
Other Income 0.310.040.010.081.010.070.554.160.020.720.010.210.12
Interest 1.151.241.471.081.251.591.521.211.431.491.571.581.69
Depreciation 1.691.661.981.251.030.980.980.570.470.470.400.440.39
Profit before tax -2.14-1.77-3.11-4.29-0.990.561.012.57-2.28-3.56-1.83-4.92-2.91
Tax % 1.40%67.23%31.51%26.11%34.34%71.43%39.60%-0.39%0.00%0.00%0.00%0.00%0.00%
Net Profit -2.17-2.96-4.09-5.42-1.340.160.612.58-2.28-3.56-1.84-4.92-2.90
EPS in Rs -1.05-1.44-1.99-2.63-0.650.080.301.25-1.11-1.73-0.89-2.39-1.41

Last Updated: January 11, 2026, 5:17 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: December 15, 2025, 4:52 am

MetricMar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022TTM
Sales 1071672022101933193171984357452319
Expenses 851341651771642742592414457382926
Operating Profit 21333633294557-43-1-07-6-6
OPM % 20%20%18%16%15%14%18%-22%-3%-0%16%-25%-32%
Other Income 146659-161-49120511
Interest 5871211172226155666
Depreciation 26662411887422
Profit before tax 152329212033-137-127-12-113-13-13
Tax % 31%29%28%30%12%33%-20%-18%46%29%36%0%
Net Profit 101621151822-109-104-17-152-13-13
EPS in Rs 5.178.3910.617.458.7010.78-53.09-50.47-8.19-7.100.98-6.12-6.42
Dividend Payout % 19%15%14%20%17%14%0%0%0%0%0%0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2011-20122012-20132013-20142014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-2022
YoY Net Profit Growth (%)60.00%31.25%-28.57%20.00%22.22%-595.45%4.59%83.65%11.76%113.33%-750.00%
Change in YoY Net Profit Growth (%)0.00%-28.75%-59.82%48.57%2.22%-617.68%600.04%79.07%-71.89%101.57%-863.33%

Omkar Speciality Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2011-2012 to 2021-2022.

Growth

Compounded Sales Growth
10 Years:-18%
5 Years:-41%
3 Years:-19%
TTM:-59%
Compounded Profit Growth
10 Years:%
5 Years:%
3 Years:16%
TTM:-345%
Stock Price CAGR
10 Years:-22%
5 Years:-3%
3 Years:-33%
1 Year:-34%
Return on Equity
10 Years:%
5 Years:%
3 Years:%
Last Year:%

Last Updated: September 5, 2025, 11:55 am

Advertisements

Balance Sheet

Last Updated: September 22, 2026, 6:00 am

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital 20.5820.5820.5820.5820.5820.5820.5820.5820.5820.5820.58
Reserves 142.37160.87-23.39-145.66-168.66-183.07-178.91-191.63-373.81-375.78-1.85
Borrowings 175.51185.76180.65232.71229.50233.31228.09225.51382.36382.353.11
Other Liabilities 50.1379.52135.4928.4825.7726.4516.6117.7117.2422.0823.81
Total Liabilities 388.59446.73313.33136.11107.1997.2786.3772.1746.3749.2345.65
Fixed Assets 68.3077.90168.4776.2968.4353.1427.9126.1221.8820.8619.07
CWIP 107.35112.670.000.000.000.000.000.000.000.000.20
Investments 13.8013.910.1410.920.350.380.710.430.070.070.07
Other Assets 199.14242.25144.7248.9038.4143.7557.7545.6224.4228.3026.31
Total Assets 388.59446.73313.33136.11107.1997.2786.3772.1746.3749.2345.65

Reserves and Borrowings Chart

Cash Flow

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity + 52.85-9.40107.3025.961.384.02-16.410.89-124.180.200.91-1.60
Cash from Investing Activity + -76.0611.71-119.90-64.3310.901.5117.350.170.29-0.170.11-0.13
Cash from Financing Activity + 17.33-7.9115.7535.24-13.55-5.30-1.08-1.04124.400.000.00-0.05
Net Cash Flow -5.88-5.593.16-3.13-1.280.23-0.140.030.500.031.02-1.78
Free Cash Flow -13.54-28.6146.77-28.421.265.520.820.89-121.020.130.91-1.80
CFO/OP 187%-26%-233%-61%-106%-1,608%-222%-16%4,740%-19%-147%186%

Free Cash Flow

Free cash flow reported in the stored cash-flow statement (₹ Cr)
PeriodMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Free Cash Flow-13.54-28.6146.77-28.421.265.520.820.89-121.020.130.91-1.80

This table and the chart use the Free Cash Flow row from the same stored cash-flow statement. Free cash flow generally measures operating cash flow after capital expenditure; check the source definition and reporting basis. It is not operating profit minus borrowings.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022
Debtor Days 93841111481291179019743011133
Inventory Days 14716817015614999110837311840
Days Payable 106817394968118432259148139215
Cash Conversion Cycle 13517220921018113516-5-147-86-10-143
Working Capital Days 68526-10-8938-81-296-1,361-1,002-1,065-3,296
ROCE %22%19%17%12%10%14%18%-34%-8%-8%7%-11%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthDec 2019Mar 2020Jun 2020Sep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Jun 2026
Promoters 27.62%27.62%27.62%27.62%27.62%14.71%27.62%17.62%17.62%14.71%14.71%95.00%
FIIs 0.00%0.00%0.00%0.00%0.00%0.06%0.00%0.01%0.00%0.06%0.06%0.00%
DIIs 0.03%0.01%0.01%0.01%0.01%0.01%0.01%0.00%0.01%0.01%0.01%0.00%
Public 72.35%72.38%72.38%72.38%72.38%85.22%72.38%82.36%82.37%85.22%85.22%5.00%
No. of Shareholders 19,50719,08718,96518,67818,27319,43017,46119,15219,31819,43019,4302

Shareholding Pattern Chart

No. of Shareholders

Omkar Speciality Chemicals Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 16Mar 15Mar 14Mar 13Mar 12
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) 14.8812.036.9110.478.15
Diluted EPS (Rs.) 14.8812.036.5910.468.15
Cash EPS (Rs.) 19.2616.8213.0513.8811.03
Book Value[Excl.RevalReserv]/Share (Rs.) 94.9981.9269.9164.7453.71
Book Value[Incl.RevalReserv]/Share (Rs.) 94.9981.9269.9164.7453.71
Revenue From Operations / Share (Rs.) 200.90128.84122.42107.8585.06
PBDIT / Share (Rs.) 39.9625.7923.5322.5318.53
PBIT / Share (Rs.) 35.5820.7717.3919.1215.65
PBT / Share (Rs.) 25.4513.7310.0415.2911.52
Net Profit / Share (Rs.) 14.8811.806.9110.478.15
NP After MI And SOA / Share (Rs.) 14.8811.806.9110.478.15
PBDIT Margin (%) 19.8920.0119.2220.8821.78
PBIT Margin (%) 17.7016.1114.2017.7218.39
PBT Margin (%) 12.6610.658.2014.1713.54
Net Profit Margin (%) 7.409.155.649.719.58
NP After MI And SOA Margin (%) 7.409.155.649.719.58
Return on Networth / Equity (%) 15.6614.409.8816.1715.17
Return on Capital Employeed (%) 24.0818.4516.7520.3823.00
Return On Assets (%) 5.255.063.366.246.73
Long Term Debt / Equity (X) 0.480.350.470.420.24
Total Debt / Equity (X) 1.061.191.391.140.90
Asset Turnover Ratio (%) 0.640.480.620.770.85
Current Ratio (X) 0.970.831.081.321.33
Quick Ratio (X) 0.610.470.650.810.82
Inventory Turnover Ratio (X) 2.221.491.382.052.60
Dividend Payout Ratio (NP) (%) 10.0812.7121.7114.3215.33
Dividend Payout Ratio (CP) (%) 7.788.9111.4910.8011.32
Earning Retention Ratio (%) 89.9287.2978.2985.6884.67
Cash Earning Retention Ratio (%) 92.2291.0988.5189.2088.68
Interest Coverage Ratio (X) 4.043.663.225.884.49
Interest Coverage Ratio (Post Tax) (X) 2.522.681.953.732.98
Enterprise Value (Cr.) 556.39517.22461.39345.22178.59
EV / Net Operating Revenue (X) 1.351.951.921.631.07
EV / EBITDA (X) 6.779.759.997.814.91
MarketCap / Net Operating Revenue (X) 0.861.251.201.060.69
Retention Ratios (%) 89.9187.2878.2885.6784.66
Price / BV (X) 1.841.972.101.771.10
Price / Net Operating Revenue (X) 0.861.251.201.060.69
EarningsYield 0.080.070.040.090.13

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Frequently asked questions

What is the intrinsic value of Omkar Speciality Chemicals Ltd and is it undervalued?

Omkar Speciality Chemicals Ltd: the stored intrinsic value estimate is ₹12.64, compared with a stored share price of ₹3.41. The model value is 270.7% above that quote. The model classifies this as undervalued; it is an estimate dependent on the inputs and assumptions, not a price target or a buy/sell recommendation. The estimate uses the available valuation models and weights shown in the Intrinsic Value panel, including earnings, cash-flow and asset-based approaches where data permits. It is not a P/E-only calculation.

What share price and 52-week range are shown for Omkar Speciality Chemicals Ltd?

The stored share price is ₹3.41. Price-data record updated: 24 September 2026, 3:09 am +05:30. This is not a live quote. The stored 52-week high / low is 6.40/3.35; this is a rolling range, not a financial-year range.

How have Omkar Speciality Chemicals Ltd's revenue and profit changed?

Revenue for Mar 2022 was ₹23.00 Cr, versus ₹45.00 Cr in Mar 2021 (-48.9% year on year). Net profit for Mar 2022 was ₹-13.00 Cr, versus ₹2.00 Cr in Mar 2021. These are the latest annual periods stored on this page; check the quarterly table separately for more recent developments.

Does Omkar Speciality Chemicals Ltd's profit convert into cash?

For the same Mar 2022 period, operating cash flow was ₹0.89 Cr against net profit of ₹-13.00 Cr.A cash-to-profit ratio is not meaningful with zero or negative profit.

What should I check in Omkar Speciality Chemicals Ltd's balance sheet?

Reported borrowings were ₹3.11 Cr in Mar 2026. Read this alongside cash, interest costs and repayment obligations; reserves are an accounting balance and are not the same as available cash.

What could change Omkar Speciality Chemicals Ltd's intrinsic value estimate?

Changes in sustainable earnings, cash generation, capital needs, debt and share count can change the estimate. The displayed model uses a 12% cost of equity and 4% terminal growth assumption where applicable. Higher discount rates or weaker growth generally reduce discounted values. Compare the individual model values and weights, and verify fresh filings before relying on the result.

Advertisements
Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Omkar Speciality Chemicals Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE